Trailing-twelve-month (TTM) revenue is $3.08 Billion with a year-over-year growth of (1.16%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-27 | $678,178,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-26 |
| Q1 FY2026Period ended 2025-12-27 | $617,373,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q2 FY2026Period ended 2026-03-28 | $906,152,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q3 FY2026Period ended 2026-06-27 | $882,362,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $3,084,065,000 |
Current P/S: $2,504,082,536 market capitalization ÷ $3,084,065,000 TTM revenue = 0.81x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-27): $882.36M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:36:12.869Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2021-09-25 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-26 · USD | FY20212021-09-25 · USD | FY20222022-09-24 · USD | FY20232023-09-30 · USD | FY20242024-09-28 · USD | FY20252025-09-27 · USD |
|---|---|---|---|---|---|---|
| Garden Products Segment | $1.1B | $1.4B | $1.5B | $1.4B | $1.4B | $1.3B |
| Pet Products Segment | $1.6B | $1.9B | $1.9B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-09-24 · USD | FY20172017-09-30 · USD | FY20182018-09-29 · USD | FY20192019-09-28 · USD | FY20202020-09-26 · USD | FY20212021-09-25 · USD |
|---|---|---|---|---|---|---|
| Garden Products Segment | N/A | N/A | N/A | $998M | $1.1B | $1.4B |
| Pet | $1.1B | $1.2B | $1.3B |
$3.08B
$3.08 Billion
(1.16%)
vs. $3.12B a year ago (TTM)
(0.98%)
5 Year compound annual growth rate
1 Year
(1.16%)
3 Year
(1.90%)
5 Year
(0.98%)
10 Year
+5.52%
15 Year
+4.48%
20 Year
+3.59%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.13B | ($71.40M) | (2.23%) |
| 2024 | $3.20B | ($109.62M) | (3.31%) |
| 2023 | $3.31B | ($28.50M) | (0.85%) |
| 2022 | $3.34B | +$34.90M | +1.06% |
| 2021 | $3.30B | +$608.17M | +22.56% |
| 2020 |
TTM Growth
(1.16%)
3-Year CAGR
(1.90%)
5-Year CAGR
(0.98%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:36:12.869Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.8B |
| $1.8B |
| N/A |
| N/A |
| Pet Products Segment | N/A | N/A | N/A | $1.4B | $1.6B | $1.9B |
|---|
| $2.70B |
| +$312.50M |
| +13.11% |
| 2019 | $2.38B | +$167.65M | +7.57% |
| 2018 | $2.22B | +$160.88M | +7.83% |
| 2017 | $2.05B | +$225.46M | +12.33% |
| 2016 | $1.83B | +$178.28M | +10.80% |
